Wells Fargo Upgrades Kymera Therapeutics (KYMR) to Overweight

December 2, 2024 5:14 AM EST Send to a Friend
(Updated - December 2, 2024 6:44 AM EST)

Wells Fargo analyst Derek Archila upgraded Kymera Therapeutics (NASDAQ: KYMR) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login